|
Zefur® Manufacturer: Metz PharmaClass: Cephalosporins |
 |
 | |
| Contents | Cefuroxime axetil |
| Indications | Treatment of susceptible infections including bone & joint infections, bronchitis, gonorrhea, otitis media, peritonitis, pharyngitis, sinusitis, skin & soft tissue infections & UTIs. |
| Dosage | Adult Respiratory tract infections 250-500 mg bid. |
| Administration | Should be taken with food |
| Contraindications | Hypersensitivity to cephalosporins. |
| Adverse Drug Reactions | Skin rashes, urticaria, eosinophilia, fever, reactions resembling serum sickness & anaphylaxis. |
| Drug Interactions | Probenecid. |
| Pregnancy Category (US FDA) | Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
| ATC Classification | J01DC02 - Cefuroxime ; |
| Poison Schedule | Rx |
PACKING / PRESENTATION
| Form | Packing/Price |
| Tablet | 500 mg x 8's, 40's |